World7 months ago
Spanish Real-World Study: Adalimumab Biosimilar MSB11022 Safe, Effective in IBD
A real-world study conducted in Spain on patients with inflammatory bowel disease (IBD) receiving either the adalimumab originator or biosimilar MSB11022 (Idacio; Fresenius Kabi) found “no...
